Cryptococcus neoformans: Virulence and host defences

Medical Mycology, Supplement

Volumn 36, Issue 1, 1998, Pages 79-86

  Perfect, J R ^a   Wong, B ^b,c   Chang, Y C ^d   Kwon Chung, K J ^d   Williamson, P R ^e  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Cryptococcus neoformans; Molecular biology; Virulence

Indexed keywords

MANNITOL; MELANIN; POLYOL;

BIOCHEMISTRY; CONFERENCE PAPER; CRYPTOCOCCUS NEOFORMANS; GENE EXPRESSION; HOST RESISTANCE; MOLECULAR GENETICS; NONHUMAN; VIRULENCE; YEAST;

CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; GENE EXPRESSION REGULATION, FUNGAL; GENES, FUNGAL; HUMANS; MELANINS; POLYSACCHARIDES; VIRULENCE;

EID: 0032310964     PISSN: 09668454     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (35)

1. Pinner RW, Hajjeh RA, Powderly WG. Prospects for preventing cryptococcosis in persons infected with human immunodeficiency virus. Clinical Infectious Diseases 1995; 21 (Suppl. 1): S103-S107.
2. Chang Y, Kwon-Chung KJ. Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence. Molecular and Cellular Biology 1994; 14: 4912-4919.
3. Chang Y, Penoyer L, Kwon-Chung KJ. The second capsule gene of Cryptococcus neoformans CAP64 is essential for virulence. Infection and Immunity 1996; 64: 1977-1983.
4. Falkow S. Molecular Koch's postulates applied to microbial pathogenicity. Reviews of Infectious Diseases 1988: 10 (Suppl. 2): 5274-5276
5. Wong B, Bernard EM, Gold JWM, Fong D, Silber A, et al. Increased arabinitol levels in experimental acandidiasis in rats: arabinitol appearance rates, arabmitol/creatinine ratios, and severity of infection Journal of Infectious Diseases 1982; 141: 346-352.
6. Wong B, Brauer KL. Enantioselective measurement of fungal D-arabinitol in the sera of normal adults and patients with candidiasis. Journal of Clinical Microbiology 1988; 26: 1670-1674.
7. Wong B, Brauer KL, Tsai RR, Jayasimhulu K. Increased amounts of the Aspergillus metabolite D-mannitol in the tissues and sera of rats with experimental aspergillosis. Journal of Infectious Diseases 1989; 160: 95-103.
8. Wong B, Perfect JR, Beggs S, Wright K. Production of the hexitol D-mannitol by Cryptococcus neoformans in vitro and in rabbits with experimental meningitis. Infection and Immunity 1990; 58: 1664-1670.
9. Chaturvedi VP, Flynn T, Niehaus WG, Wong B. Stress tolerance and pathogenic potential of a mannitol-mutant of Cryptococcus neoformans. Microbiology 1996; 142: 937-943.
10. Chaturvedi VP, Wong B, Newman SL. Oxidative killing of Cryptococcus neoformans by human neutrophills: evidence that fungal mannitol protects by scavenging oxidants. Journal of Immunology 1996; 156: 3836-3840.
11. Tarczynski MC, Jensen RG, Bohnert HJ. Stress protection of transgenic tobacco by production of the osmolyte mannitol Science 1993; 259: 508-510.
12. Chaturvedi VP, Bartiss A, Wong B. Expression of bacterial mtlD in Saccharomyces cerevisiae results in mannitol synthesis and protects a glycerol-defective mutant from high-salt and oxidative stress. Journal of Bacteriology 1997; 179: 157-162.
13. Kwon-Chung KJ, Polacheck I, Popkin TJ Melanin-lacking mutants of Cryptococcus neoformans and their virulence for mice. Journal of Biological Chemistry 1982; 150: 1414-1421.
14. Kwon-Chung KJ, Rhodes JC. Encapsulation and melanin formation as indicators of virulence in Cryptococcus neoformans. Infection and Immunity 1986; 51: 218-223.
15. Rhodes JC, Polacheck I, Kwong-Chung KJ. Phenoloxidase activity and virulence in isogenic strains of Cryptococcus neoformans. Infection and Immunity 1982; 36: 1175-1184.
16. Wang Y, Aisen P, Casadevall A. Cryptococcus neoformans melanin and virulence: mechanism of action. Infection and Immunity 1995; 63: 3131-3136.
17. Williamson PR. Biochemical and molecular characterization of diphenol oxidase of Cryptococcus neoformans: Identification as a laccase. Journal of Bacteriology 1994; 176: 656-664.
18. Salas SD, Bennett JE, Kwon-Chung KJ, Perfect JR, Williamson PR. Effect of the laccase gene, CNLAC1, on virulence of Cryptococcus neoformans. Journal of Experimental Medicine 1996; 184: 377-386.
19. Mekalanos JJ. Environmental signals controlling expression of virulence determinants in bacteria. Journal of Bacteriology 1992; 174: 1-7.
20. Tanaka M, Herr W. Differential transcriptional activation by Oct-1 and Oct-2: interdependent activation domains induce Oct-2 phosphorylation. Cell 1990; 60: 375-386.
21. Mermod N, O'Neill EA, Kelly TJ, Tjian R. The proline-richtranscriptional activator of CTF/NF-I is distinct from the replication and DNA binding domain. Cell 1989; 58: 741-753.
22. Hope LA, Struhl K. Functional dissection of a eukaryotic transcriptional activator protein, GCN4 of yeast. Cell 1986; 46: 885-894.
23. Horikoshi M, Carey MF, Kakidani H, Roeder RE. Mechanism of action of a yeast activator: direct effect of GAL4 derivatives on mammalian TFIID-promoter interactions. Cell 1988; 54: 665-669.
24. Pugh BF, Tijian R. Mechanism of transcriptional activation by Sp1 evidence for coactivators. Cell 1990; 61: 1187-1197.
25. Lue NF, Kornberg RD. Accurate initiation at RNA polymerase II promoters in extracts from Saccharomyces cerevisiae. Proc Ntl Acad Sci USA 1987; 84: 8839-8843.
26. Descheemaeker KA, Wyn S, Nelles L, Auwerx J, Ny T, et al. Interaction of AP-1, AP-2 and Sp1-like proteins with two distinct sites in the upstream regulatory region of the plasminogen activator inhibitor-1 gene mediates phorbol 12-myristate 13-acetate response. Journal of Biological Chemistry 1992; 267: 15086-15091.
27. Perfect JR. Fungal virulence genes as targets for antifungal chemotherapy. Antimicrobial Agents and Chemotherapy 1996; 40: 1577-1583.
28. Odom A, Muir S, Lim E, Toffaletti DL, Perfect JR, et al. Calcineurin is required for virulence of Cryptococcus neoformans. EMBO Journal (Oxford) 1997; in press.
29. Rude TH, Perfect JR. Isolation and Identification of several site-specific genes of Cryptococcus neoformans differentially expressed in the CNS. American Society for Microbiology, abstract 1994; F-49.
30. Liang P, Pardee AB. Differential display of eucaryotic messenger RNA by means of the polymerase chain reaction. Science 1992; 257: 967-971.
31. Duguid JR, Rohwa RG, Seed B. Isolation of cDNA of scropie - modulated RNAs by substractive hybridization of cDNA library. Proc Ntl Acad Sci USA 1988; 85: 5738-5742.
32. Velculesou VE, Zhang L, Vogelstein B, Kinzler KW. Serial analysis of gene expression. Science 1995; 270: 484-487.
33. Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microassay. Science 1995; 270: 467-470.
34. Mahan MJ, Slauch JM, Mekalanos JJ. Selection of bacterial virulence genes that are specifically induced in host tissues. Science 1993; 259: 686-688.
35. Perfect JR, Toffaletti DL, Rude TH. The gene encoding for phosphoribosylaminoimidazole carboxylase (ADE2) is essential for growth of Cryptococcus neoformans in cerebrospinal fluid. Infection and Immunity 1993; 61: 4446-4451.